Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease.

ABSTRACT:

Importance

In the US, hepatocellular carcinoma (HCC) has been the most rapidly increasing cancer since 1980, and metabolic dysfunction-associated steatotic liver disease (MASLD) is expected to soon become the leading cause of HCC.

Objective

To develop a prediction model for HCC incidence in a cohort of patients with MASLD.

Design, setting, and participants

This prognostic study was conducted among patients aged at least 18 years with MASLD, identified using diagnosis of MASLD using International Classification of Diseases, Ninth Revision (ICD-9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnosis codes; natural language processing of radiology imaging report text, which identified patients who had imag

SUBMITTER: Rodriguez LA 

PROVIDER: S-EPMC11240192 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature